Nanosphere Respiratory Panel Categorized as Moderate Complexity | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today said that the US Food and Drug Administration has notified the firm that its Verigene SP respiratory virus panel has been categorized as "moderate complexity" under the Clinical Laboratory Improvement Amendments of 1988.

The test runs on the firm's Verigene SP molecular diagnostics system, the newer version of its flagship Verigene platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.